Several committees provide advice to the OTA Board on relevant matters related to organ and tissue donation and transplantation in Australia and the operations of the OTA.
- The OTA’s committee structure is shown below:
Following is a list of the OTA's committees, their membership and their functions.
The Audit Committee
The Audit Committee has been established in compliance with section 45 of the Public Governance, Performance and Accountability Act 2013 (PGPA Act) and PGPA Rule section 17 – Audit committee for Commonwealth entities.
The committee provides independent assurance to the OTA Board on the OTA’s financial and performance reporting responsibilities, risk oversight and management, and system of internal control.
The Audit Committee comprises two independent external members (Chair Mr Peter Hoefer, Deputy Chair Ms Glenys Roper) and one internal member. The Chief Executive Officer representing the OTA Board, the General Manager and representatives from the Australian National Audit Office and internal audit staff are invited to attend each meeting.
Jurisdictional Advisory Group (JAG)
The Jurisdictional Advisory Group is the premier advisory committee for the DonateLife Network. The group is chaired by the CEO and comprises the National Medical Director, State and Territory Medical Directors and jurisdictional health department representatives. The group considers and makes recommendations to the OTA Board in respect of strategic priorities, clinical and data governance, planning and leadership of the DonateLife Network, and implementation of the Australian Government's national program on organ and tissue donation.
2017 - 2016 JAG Communiqués
2017 Jurisdictional Advisory Group Communiqués
2016 Jurisdictional Advisory Group Communiqués
2015 - 2010 JAG Communiqués
2015 Jurisdictional Advisory Group Communiqués
2014 Jurisdictional Advisory Group Communiqués
2013 Jurisdictional Advisory Group Communiqués
2012 SMD Communiques
2011 SMD Communiques
2010 SMD Communiques
Clinical Governance Committee (CGC)
The Clinical Governance Committee pursues specific clinical issues relevant to the DonateLife Network. The committee is chaired by the National Medical Director and comprises the CEO, State and Territory Medical Directors and Agency/Clinical/Operational Managers from each state and territory. The committee makes recommendations related to the clinical aspects of the national program for consideration by the Jurisdictional Advisory Group.
Transplant Liaison Reference Group (TLRG)
The Transplant Liaison Reference Group provides advice to the OTA Board on transplantation issues relevant to the national program and facilitates engagement with the transplant sector. Membership comprises the CEO, the National Medical Director and representatives from the Transplantation Society of Australia and New Zealand, Australasian Transplant Coordinators Association, Transplant Australia, Transplant Nurses Association, Australia and New Zealand Organ Donation Registry, and Australia and New Zealand Intensive Care Society
Vigilance and Surveillance Expert Advisory Committee (VSEAC)
The Vigilance and Surveillance Expert Advisory Committee is a newly established committee which is monitoring performance of the vigilance and surveillance system, advising on emerging risks identified in the organ and tissue donation and transplantation sectors, and providing advice and recommendations for action where appropriate.
The VSEAC membership comprises high level technical specialists with relevant expertise from key clinical and community stakeholders, government and professional organisations.